Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ZERBAXA (ceftolozane/ tazobactam)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ZERBAXA (ceftolozane/ tazobactam)

Medicine - Posted on Jan 09 2023
Active substance (DCI)
  • ceftolozane
  • tazobactam
history (3)
  • 12/14/22

    ZERBAXA (ceftolozane/tazobactam) - Traitement des infections chez les enfants (de la naissance à moins de 18 ans)

    Key points Approval of reimbursement as for adults, in the marketing authorisation indications only as a last resort for the...
    CAV :
    54321
    icône flèche
  • 1/22/20

    ZERBAXA (ceftolozane/ tazobactam)

    Key points Favourable opinion for reimbursement in the MA indications only as a last resort for the treatment of patients wi...
    CAV :
    54321
    icône flèche
  • 7/6/16

    ZERBAXA, (ceftolozane/tazobactam), cephalosporin and β-lactamase inhibitor

    No clinical benefit demonstrated in the management of intra-abdominal infections, acute pyelonephritis and complicated urina...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • J01DI54
Manufacturer
MSD FRANCE
Presentation

ZERBAXA 1 g/0,5 g, poudre pour solution à diluer pour perfusion (code CIS : 65166404)
10 flacon(s) en verre de 20 ml (CIP : 34009 300 362 3 5)

All our publications
    Bacterial infections Digestive system diseases - miscellaneous Drug therapy Kidney diseases Paediatrics Urologic diseases - miscellaneous

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
X8w45v3pMp56Gtex